Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3

Authors :: da Cunha-Santos, Gilda
Dhani, Neesha
Tu, Dongsheng
Chin, Kayu
Ludkovski, Olga
kamel-Reid, Suzanne
Squire, Jeremy
Parulekar, Wendy
Moore, Malcolm J.
Tsao, Ming Sound
Source :: Cancer. Dec 15, 2010, Vol. 116 Issue 24, p5599, 9 p.
Publication Year :: 2010

Subjects :: Pancreatic cancer -- Care and treatment
Pancreatic cancer -- Patient outcomes
Pancreatic cancer -- Research
Gemcitabine -- Dosage and administration
Gemcitabine -- Complications and side effects
Gemcitabine -- Research
Erlotinib -- Dosage and administration
Erlotinib -- Complications and side effects
Erlotinib -- Research
Health

Tools